Stock Analiz

Quest Diagnostics Inc. (DGX) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Quest Diagnostics’s revenue went from $7.2B in fiscal 2016 to $11.0B in fiscal 2025, growth of about 4.8% a year.

Net income in fiscal 2025 was $992M, a net margin of 9.0%; the best year in this period was 2021 with $2.0B.

Over the twelve months to September 30, 2026, revenue was $11.8B and net income $1.1B.

Free cash flow was $1.4B in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count fell 20% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2016: $7.2B162017: $7.4B172018: $7.5B182019: $7.7B192020: $9.4B202021: $10.8B212022: $9.9B222023: $9.3B232024: $9.9B242025: $11.0B25$11.0B
Net income
2016: $645M162017: $772M172018: $736M182019: $858M192020: $1.4B202021: $2.0B212022: $946M222023: $854M232024: $871M242025: $992M25$992M
Free cash flow
2016: $823M162017: $923M172018: $817M182019: $843M192020: $1.6B202021: $1.8B212022: $1.3B222023: $864M232024: $909M242025: $1.4B25$1.4B
EPS (diluted)
2016: $4.51162017: $5.50172018: $5.29182019: $6.28192020: $10.47202021: $15.55212022: $7.97222023: $7.49232024: $7.69242025: $8.7525$8.75

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$11.8B$11.0B$9.9B$9.3B$9.9B$10.8B$9.4B$7.7B$7.5B$7.4B$7.2B
Gross profit$3.9B$3.7B$3.2B$3.1B$3.4B$4.2B$3.6B$2.7B$2.6B$2.7B$2.9B
Operating income$1.7B$1.6B$1.3B$1.3B$1.4B$2.4B$2.0B$1.2B$1.1B$1.2B$1.3B
Net income$1.1B$992M$871M$854M$946M$2.0B$1.4B$858M$736M$772M$645M
EPS (diluted)$10.04$8.75$7.69$7.49$7.97$15.55$10.47$6.28$5.29$5.50$4.51
R&D———————————
Revenue growth—+11.8%+6.7%−6.4%−8.4%+14.3%+22.1%+2.6%+1.7%+2.6%−3.7%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$2.0B$1.9B$1.3B$1.3B$1.7B$2.2B$2.0B$1.2B$1.2B$1.2B$1.1B
Capital spending-$576M-$527M-$425M-$408M-$404M-$403M-$418M-$400M-$383M-$252M-$293M
Free cash flow$1.4B$1.4B$909M$864M$1.3B$1.8B$1.6B$843M$817M$923M$823M
Dividends paid$369M$353M$331M$314M$305M$309M$297M$286M$266M$247M$223M
Buybacks$552M$450M$151M$275M$1.4B$2.2B$325M$353M$322M$465M$590M
Stock-based pay$88M$88M$88M$77M$77M$79M$97M$56M$61M$79M$69M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$420M$549M$686M$315M$872M$1.2B$1.2B$135M$137M$359M
Debt—$6.4B$6.9B$5.4B$4.6B$4.7B$4.7B$5.3B$4.4B$3.8B$3.7B
Equity—$7.2B$6.8B$6.3B$5.9B$6.4B$6.8B$5.6B$5.2B$4.9B$4.6B
Total assets—$16.2B$16.2B$14.0B$12.8B$13.6B$14.0B$12.8B$11.0B$10.5B$10.1B
Shares (diluted)112M113M113M113M118M128M136M136M139M140M142M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin33.1%33.2%32.9%33.0%34.7%39.0%38.5%34.8%34.6%36.2%40.2%
Operating margin14.6%14.1%13.6%13.6%14.4%22.1%20.9%15.9%14.6%15.7%17.7%
Net margin9.5%9.0%8.8%9.2%9.6%18.5%15.2%11.1%9.8%10.4%8.9%
FCF margin11.6%12.3%9.2%9.3%13.3%17.0%16.8%10.9%10.8%12.5%11.4%
ROIC—8.8%7.5%8.4%10.7%16.5%13.1%8.6%9.2%10.2%9.2%
ROE—13.8%12.8%13.5%16.1%31.0%21.2%15.2%14.1%15.7%13.9%

Frequently asked questions

What is Quest Diagnostics’s annual revenue?

$11.0B in fiscal 2025 and $11.8B over the twelve months to September 30, 2026.

How much profit does Quest Diagnostics make?

Net income was $992M in fiscal 2025 (net margin 9.0%).

Is Quest Diagnostics’s revenue growing?

Yes: revenue rose 11.8% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.